clinical trial · NCT04326946
International Alfapump Cohort Study
Sequana Medical N.V.·—·active not recruiting·n = 400
Liver CirrhosesMalignant AscitesAlfapump
brief summary
This Registry is designed to follow patients who have been implanted with an alfapump system, which is a newly marketed product from Sequana Medical AG, a Swiss Medical Device company.
started
Aug 14, 2018
primary completion
Dec 31, 2028
completion
Dec 31, 2030
last updated
Nov 12, 2024
detailed description
In a real-world setting, all patients implanted with an alfapump system according to it's intended use, not participating in another clinical study in which the alfapump is studied.
official title
International Alfapump Cohort Study: in Patients With Refractory Ascites Due to Liver Cirrhosis or Malignant Ascites With a Life Expectancy of 6 Months or Less
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol